October 1, 2020
Consumer-friendly telehealth and mail-order wellness product service Hims is officially entering the public markets. Today it announced a merger agreement with Oaktree Capital Management-sponsored special purpose acquisition company (SPAC) Oaktree Acquisition Corp.
The reverse merger is expected to close in the fourth quarter of 2020, and places the combined entity at a roughly $1.6 billion...
September 11, 2020
About the authors: Andrew Dudum is the CEO and founder of Hims & Hers, a consumer-facing digital health company offering telehealth services.
Joel White is executive director of the Health Innovation Alliance, a coalition of health and technology leaders who support policies that use technology and data to make healthcare work better.
Outside of these positions, Dudum and White report no...
August 3, 2020
Austin, Texas-based virtual and on-demand care provider Remedy announced Dr. Ronald Dixon as its chief medical officer. Dixon, formerly the head of clinical affairs at Onduo and the president and CEO of Onduo Professionals (its provider staffing group), is expected to draw on his experience to help Remedy build out its virtual chronic care treatment services.
“Dr. Dixon’s experience in developing...
July 30, 2020
D2C wellness and telehealth startup Hims & Hers is looking to cut down the time between medication orders and delivery for certain customers.
Thanks to a newly announced partnership, patients receiving virtual primary care services through Hims & Hers may choose to select Alto as their preferred pharmacy for prescription deliveries. They will have their orders fulfilled automatically ...
July 23, 2020
Consumer wellness and telehealth company Hims could be the next to throw its hat into the public markets.
According to a report from Reuters, the startup is weighing a potential sale to an unnamed special purpose acquisition company (SPAC) – a "blank-check company" that uses the proceeds of an IPO to acquire or merge another business.
The deal would value Hims at over $1 billion, Reuters' sources...
May 13, 2020
Less than a week after the first home-collected saliva test for COVID-19 was authorized by the FDA, at least two consumer-facing telehealth brands say they have cut deals to sell these test kits to the public.
The first is consumer telehealth company Hims & Hers, best known for its mail-order wellness and sexual health products for men and women.
While the well-funded startup has...
April 8, 2020
Easy access to (temporarily) free counseling. Consumer telehealth and mail-order prescription services Hims and Hers are dipping into the mental health wellness space. The brands kicked off new anonymized group therapy and guided meditation offerings yesterday, with the therapy sessions led by a licensed mental health practitioner.
The group sessions are currently being offered free of charge in...
November 14, 2019
Hims & Hers, an online mail-order health company that uses remote consultations to prescribe cosmetic and sexual health products, has rolled out a new app for users.
The app will offer almost identical services and links as the original platform, and will give users access to asynchronous healthcare visits and prescription products such as birth control and erectile dysfunction medication...
October 1, 2019
Sixth time's the charm? Roche’s Accu-Chek Connect Diabetes Management App has notched its sixth device recall from the FDA, this time due to meter-to-app data transfer issues for users with Android OS 8.0 and above. According to the agency’s posting, Roche notified partners, users and call centers of the issue and released and update addressing the problem before the end of that month.
September 12, 2019
There are some striking similarities between mail-order sexual health companies Ro and Hims: Both started out focused on men’s sexual health, both employ telemedicine and if you ride the subway in a major city you’ve probably seen their advertisements.
But things are getting heated this week after Hims launched an updated version of its platform. On Tuesday, Ro cofounder Zachariah Reitano...